These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 36270340)

  • 1. The impact of type 2 diabetes duration on serum asymmetric dimethylarginine and C-reactive protein concentration in Bosnian patients.
    Zaciragic A; Dervisevic A; Avdagic N; Babic N; Valjevac A; Lepara O; Huskic J
    Endocr Regul; 2022 Oct; 56(4):271-278. PubMed ID: 36270340
    [No Abstract]   [Full Text] [Related]  

  • 2. An assessment of correlation between serum asymmetric dimethylarginine and glycated haemoglobin in patients with type 2 diabetes mellitus.
    Začiragić A; Huskić J; Mulabegović N; Avdagić N; Valjevac A; Hasić S; Jadrić R
    Bosn J Basic Med Sci; 2014 Feb; 14(1):21-4. PubMed ID: 24579966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADMA is a correlate of insulin resistance in early-stage diabetes independent of hs-CRP and body adiposity.
    Nakhjavani M; Karimi-Jafari H; Esteghamati A; Khalilzadeh O; Asgarani F; Ghadiri-Anari A
    Ann Endocrinol (Paris); 2010 Sep; 71(4):303-8. PubMed ID: 20434720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dual behavior of heat shock protein 70 and asymmetric dimethylarginine in relation to serum CRP levels in type 2 diabetes.
    Nakhjavani M; Morteza A; Asgarani F; Khalilzadeh O; Ghazizadeh Z; Bathaie SZ; Esteghamati A
    Gene; 2012 Apr; 498(1):107-11. PubMed ID: 22349026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum asymmetric dimethylarginine and arginine levels predict microvascular and macrovascular complications in type 2 diabetes mellitus.
    Ganz T; Wainstein J; Gilad S; Limor R; Boaz M; Stern N
    Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27393712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of renal replacement therapy on plasma, asymmetric dimethylarginine, nitric oxide and C-reactive protein levels.
    Uzun H; Konukoglu D; Besler M; Erdenen F; Sezgin C; Muderrisoglu C
    Clin Invest Med; 2008; 31(1):E1-7. PubMed ID: 18312743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetes.
    Krzyzanowska K; Mittermayer F; Wolzt M; Schernthaner G
    Diabetes Care; 2007 Jul; 30(7):1834-9. PubMed ID: 17456842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADMA, C-reactive protein, and albuminuria in untreated essential hypertension: a cross-sectional study.
    Tsioufis C; Dimitriadis K; Andrikou E; Thomopoulos C; Tsiachris D; Stefanadi E; Mihas C; Miliou A; Papademetriou V; Stefanadis C
    Am J Kidney Dis; 2010 Jun; 55(6):1050-9. PubMed ID: 20189274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subarachnoid haemorrhage induces an inflammatory response followed by a delayed persisting increase in asymmetric dimethylarginine.
    Rodling-Wahlström M; Olivecrona M; Koskinen LO; Naredi S; Hultin M
    Scand J Clin Lab Invest; 2012 Oct; 72(6):484-9. PubMed ID: 22939167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic renal impairment and DDAH2-1151 A/C polymorphism determine ADMA levels in type 2 diabetic subjects.
    Marra M; Marchegiani F; Ceriello A; Sirolla C; Boemi M; Franceschi C; Spazzafumo L; Testa I; Bonfigli AR; Cucchi M; Testa R
    Nephrol Dial Transplant; 2013 Apr; 28(4):964-71. PubMed ID: 23129820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low Serum Total Bilirubin Concentration was Associated with Increased High Sensitive C Reactive Protein Level in Patients with Impaired Glucose Tolerance and Type 2 Diabetes Mellitus Subjects.
    Zheng J; Wu Y; Li Z; Wang H; Xiao W; Shi Y; Wang T
    Clin Lab; 2016; 62(5):901-7. PubMed ID: 27349017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of salivary and serum asymmetric dimethylarginine (ADMA) levels in patients with periodontal and cardiovascular disease as subclinical marker of cardiovascular risk.
    Isola G; Alibrandi A; Currò M; Matarese M; Ricca S; Matarese G; Ientile R; Kocher T
    J Periodontol; 2020 Aug; 91(8):1076-1084. PubMed ID: 31912509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased asymmetric dimethylarginine levels in young men with familial Mediterranean fever (FMF): is it early evidence of interaction between inflammation and endothelial dysfunction in FMF?
    Terekeci HM; Oktenli C; Ozgurtas T; Nalbant S; Top C; Celik S; Tapan S; Kucukardali Y; Sanisoglu YS; Solmazgul E; Sahan B; Sayan O
    J Rheumatol; 2008 Oct; 35(10):2024-9. PubMed ID: 18785307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
    Trocha M; Merwid-Ląd A; Chlebda-Sieragowska E; Szuba A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A; Sozański T
    Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric dimethylarginine is associated with high-sensitivity C-reactive protein and early carotid atherosclerosis in women with previous gestational diabetes mellitus.
    Xia W; Li D; Zhang C; Xu L; Xu W; Shao Y
    Endocrine; 2015 Mar; 48(2):528-32. PubMed ID: 24962795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between serum asymmetric dimethylarginine levels and subjective sleep quality in normotensive patients with type 2 diabetes mellitus.
    Aribas A; Kayrak M; Tekinalp M; Akilli H; Alibasic H; Yildirim S; Gunduz M; Taner A; Unlu A
    Korean J Intern Med; 2015 May; 30(3):316-24. PubMed ID: 25995662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetrical dimethylarginine is related to renal function, chronic inflammation and macroangiopathy in patients with Type 2 diabetes and albuminuria.
    Krzyzanowska K; Mittermayer F; Shnawa N; Hofer M; Schnabler J; Etmüller Y; Kapiotis S; Wolzt M; Schernthaner G
    Diabet Med; 2007 Jan; 24(1):81-6. PubMed ID: 17227328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with alpha-lipoic acid reduces asymmetric dimethylarginine in patients with type 2 diabetes mellitus.
    Mittermayer F; Pleiner J; Francesconi M; Wolzt M
    Transl Res; 2010 Jan; 155(1):6-9. PubMed ID: 20004356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated onset of senescence of endothelial progenitor cells in patients with type 2 diabetes mellitus: role of dimethylarginine dimethylaminohydrolase 2 and asymmetric dimethylarginine.
    Yuan Q; Hu CP; Gong ZC; Bai YP; Liu SY; Li YJ; Jiang JL
    Biochem Biophys Res Commun; 2015 Mar; 458(4):869-76. PubMed ID: 25701782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic inflammation is linked to low arginine and high ADMA plasma levels resulting in an unfavourable NOS substrate-to-inhibitor ratio: the Hoorn Study.
    van der Zwan LP; Scheffer PG; Dekker JM; Stehouwer CD; Heine RJ; Teerlink T
    Clin Sci (Lond); 2011 Jul; 121(2):71-8. PubMed ID: 21306304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.